Meetings, Workshops & Trainings
September 25, 2024
Learn More
Meetings, Workshops & Trainings
FDA Safety Communications
FDA Advisory Committee Meetings
Latest Publications & Presentations
Publication
04/24/2026
An FDA study using Medicare data concluded that among patients aged 65 years or older with nonvalvular atrial fibrillation (NVAF), rivaroxaban had a less favorable benefit-harm profile compared…
Publication
04/13/2026
Health information exchanges (HIEs) provide the capability to electronically move health care information among different health care information systems and store these data for downstream use…